Biotech · South San Francisco, CA · Founded 2023 · Privately Held (backing)
Developer of life-changing medicines designed through the transformative power of artificial intelligence. Xaira Therapeutics is based in South San Francisco, CA and was founded in 2023. It was valued at $3.5 billion at its early-stage round in Aug 2025, the last priced event on record. It has raised $1.3 billion across 1 recorded round; the latest was a $1 billion Series A in Apr 2024.
PMV mark · valuation
$3.5B
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$1.3B
Last round
Series A
Apr 2024
Team — not yet on record
No current team members for Xaira Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Xaira Therapeutics with a free account
·The complete investor list: 20 names
·Watch Xaira Therapeutics: the Monday email on marks, rounds and moves
